For example, one possible way to reduce tau endocytosis and subsequent spreading of tau pathology may be to decrease neuronal levels of BIN1 and PICALM (which are increased in Alzheimer's disease) in early stages of the disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.